These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36356533)
21. Preliminary evaluation of fluoro-pegylated benzyloxybenzenes for quantification of β-amyloid plaques by positron emission tomography. Yang Y; Fu H; Cui M; Peng C; Liang Z; Dai J; Zhang Z; Lin C; Liu B Eur J Med Chem; 2015 Nov; 104():86-96. PubMed ID: 26435514 [TBL] [Abstract][Full Text] [Related]
22. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804 [TBL] [Abstract][Full Text] [Related]
23. (18)F-Labeled benzylideneaniline derivatives as new ligands for beta-amyloid plaque imaging in Alzheimer's disease. Lee HJ; Jeong JM; Rai G; Lee YS; Chang YS; Kim YJ; Kim HW; Lee DS; Chung JK; Mook-Jung I; Lee MC Nucl Med Biol; 2009 Feb; 36(2):107-16. PubMed ID: 19217522 [TBL] [Abstract][Full Text] [Related]
24. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432 [TBL] [Abstract][Full Text] [Related]
25. Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease. Ono M; Cheng Y; Kimura H; Watanabe H; Matsumura K; Yoshimura M; Iikuni S; Okamoto Y; Ihara M; Takahashi R; Saji H PLoS One; 2013; 8(9):e74104. PubMed ID: 24058519 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease. Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease. Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's disease. Sundaram GS; Dhavale D; Prior JL; Sivapackiam J; Laforest R; Kotzbauer P; Sharma V EJNMMI Res; 2015 Dec; 5(1):112. PubMed ID: 26061601 [TBL] [Abstract][Full Text] [Related]
31. Antibody engagement with amyloid-beta does not inhibit [ Xiong M; Dahlén A; Roshanbin S; Wik E; Aguilar X; Eriksson J; Sehlin D; Syvänen S J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627 [TBL] [Abstract][Full Text] [Related]
32. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β. Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501 [TBL] [Abstract][Full Text] [Related]
34. Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease. Ikonomovic MD; Buckley CJ; Abrahamson EE; Kofler JK; Mathis CA; Klunk WE; Farrar G Acta Neuropathol; 2020 Oct; 140(4):463-476. PubMed ID: 32772265 [TBL] [Abstract][Full Text] [Related]
35. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 18F-labled 2-phenylindole derivatives as PET imaging probes for β-amyloid plaques. Fu H; Yu L; Cui M; Zhang J; Zhang X; Li Z; Wang X; Jia J; Yang Y; Yu P; Jia H; Liu B Bioorg Med Chem; 2013 Jul; 21(13):3708-14. PubMed ID: 23673220 [TBL] [Abstract][Full Text] [Related]
37. Preliminary PET Study of Oh SJ; Kim MH; Han SJ; Kang KJ; Ko IO; Kim Y; Park JA; Choi JY; Lee KC; Chi DY; Lee YJ; Kim KM Mol Pharm; 2017 Sep; 14(9):3114-3120. PubMed ID: 28737945 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT. Pan ML; Mukherjee MT; Patel HH; Patel B; Constantinescu CC; Mirbolooki MR; Liang C; Mukherjee J Synapse; 2016 Apr; 70(4):163-76. PubMed ID: 26806100 [TBL] [Abstract][Full Text] [Related]
39. (R)- and (S)- Song J; Zhang X; Zhao Y; Yang H; Zhang J; Zhang X; Dai J; Cui M Eur J Med Chem; 2017 Jul; 134():271-280. PubMed ID: 28419929 [TBL] [Abstract][Full Text] [Related]
40. ¹⁸F-labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques. Yu P; Cui M; Wang X; Zhang X; Li Z; Yang Y; Jia J; Zhang J; Ono M; Saji H; Jia H; Liu B Eur J Med Chem; 2012 Nov; 57():51-8. PubMed ID: 23047223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]